Page 1 of Clinical Trials for Drug ABT-335 and Rosuvastatin Calcium, 11 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
Last Updated: June 3, 2009
Condition(s): Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia
2
Completed
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
Last Updated: September 24, 2010
Condition(s): Hypercholesterolemia; Dyslipidemia
3
Completed
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium
Last Updated: October 14, 2010
Condition(s): Adverse Events; Pharmacokinetic
4
Completed
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
Last Updated: June 3, 2009
Condition(s): Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia
5
Completed
Interaction Between ABT-335, Rosuvastatin and Warfarin
Last Updated: March 22, 2011
Condition(s): Healthy
6
Completed
Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly
Last Updated: March 21, 2012
Condition(s): Dyslipidemia, Renal Insufficiency
7
Completed
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
Last Updated: January 18, 2012
Condition(s): Mixed Dyslipidemia
8
Completed
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium
Last Updated: October 19, 2010
Condition(s): Healthy
9
Completed
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
Last Updated: October 19, 2010
Condition(s): Healthy
10
Completed
30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
Last Updated: September 26, 2011
Condition(s): Dyslipidemias; Coronary Heart Disease; Kidney Disease
11
Completed
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.
Last Updated: October 19, 2010
Condition(s): Adverse Events; Pharmacokinetic Variables

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+ABT-335+and+Rosuvastatin+Calcium

Page 1 of Clinical Trials for Drug ABT-335 and Rosuvastatin Calcium, 11 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About